Research Options: Select below IPO Calendar	Week of Expected Pricing Pending Company Name ADITX THERAPEUTICS, INC Proposed Ticker ADTX CUSIP N/A Business Description A Delaware corporation, incorporated on September 28, 2017 and is located in Loma Linda, CA. The Company is a preclinical stage, life sciences company with the goal of developing nucleic acid (DNA)-based technologies to minimize rejection of transplanted organs by human recipients Lead Underwriter Dawson James Securities, Inc Co-Managers N/A Initial Shares 1,666,666 Revised Initial Shares 1,900,000 Initial Price $5.50-$5.50 Revised Price N/A Final Price N/A Final Ticker N/A
	© 2024 ICE Data Services. All rights reserved.